SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 230 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,386 | -8.3% | 413 | 0.0% | 0.00% | – |
| Q2 2023 | $12,415 | -17.0% | 413 | 0.0% | 0.00% | – |
| Q1 2023 | $14,963 | +99653.3% | 413 | 0.0% | 0.00% | – |
| Q4 2022 | $15 | -99.9% | 413 | -17.2% | 0.00% | – |
| Q3 2022 | $17,000 | -43.3% | 499 | -51.0% | 0.00% | – |
| Q2 2022 | $30,000 | -3.2% | 1,018 | +4.6% | 0.00% | – |
| Q1 2022 | $31,000 | +6.9% | 973 | 0.0% | 0.00% | – |
| Q4 2021 | $29,000 | -95.1% | 973 | -94.9% | 0.00% | -100.0% |
| Q1 2017 | $595,000 | +24.0% | 19,000 | 0.0% | 0.02% | +16.7% |
| Q4 2016 | $480,000 | +2.1% | 19,000 | 0.0% | 0.02% | -5.3% |
| Q3 2016 | $470,000 | +21.4% | 19,000 | 0.0% | 0.02% | +18.8% |
| Q2 2016 | $387,000 | +33.4% | 19,000 | 0.0% | 0.02% | +33.3% |
| Q1 2016 | $290,000 | +28.3% | 19,000 | +13.1% | 0.01% | +20.0% |
| Q4 2015 | $226,000 | – | 16,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |